Ranbaxy Mohali unit to face headwinds for a year: Surjit Pal
Pharma analyst Surjit Pal says that the recent events in the sector are very company specific but growth within the pharma sector has been taking a hit. He says that the Mohali unit for Ranbaxy will face headwinds for at least a year.
